According to Mesoblast 's latest financial reports the company's current EPS (TTM) is $63.37. In 2022 the company made an earnings per share (EPS) of $57.47 an increase over its 2021 EPS that were of -$1.20.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $58.05 | 1.02% |
2022 | $57.47 | -4897.44% |
2021 | -$1.20 | -13.08% |
2020 | -$1.38 | 17.91% |
2019 | -$1.17 | -17.18% |
2018 | -$1.41 | 141.13% |
2017 | -$0.59 | 422.52% |
2016 | -$0.11 | -94.58% |
2015 | -$2.07 |